Ga-68 labeled PSMA-11 PET

DRUG3 trials

Sponsors

University of California, San Francisco, Thomas Hope

Conditions

Prostate Cancer

Phase 2

Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence

CompletedNCT02918357

University of California, San FranciscoProstate Cancer

Start: 2016-09-15End: 2017-09-21Updated: 2019-12-02

Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients

CompletedNCT02919111

University of California, San FranciscoProstate Cancer

Start: 2016-09-23End: 2019-12-31Updated: 2020-12-10

Phase 3

Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence

CompletedNCT03353740

Thomas HopeProstate Cancer

Start: 2017-09-20End: 2020-09-01Updated: 2021-10-21

Related Papers

Pre-surgical <sup>68</sup>Ga-PSMA-11 PET for biochemical recurrence risk assessment: A surrogate of pelvic lymph node dissection? Follow-up analysis of a multicenter prospective phase 3 imaging trial.

Journal of Clinical Oncology2024-02-01

Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.

2023-07-2115 citations

Pre-surgical <sup>68</sup>Ga-PSMA-11 PET for biochemical recurrence risk assessment: A surrogate of pelvic lymph node dissection? Follow-up analysis of a multicenter prospective phase 3 imaging trial.

Journal of Clinical Oncology2023-06-01

Predictive value of extra-prostatic disease detection by pre-operative PSMA-PET for biochemical recurrence-free survival in patients treated with radical prostatectomy: Follow-up analysis of a multicenter prospective phase 3 imaging trial.

Journal of Clinical Oncology2022-06-011 citations

PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study

Journal of Nuclear Medicine2021-10-0730 citations

Diagnostic Accuracy of <sup>68</sup>Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection

JAMA Oncology2021-09-16321 citations

False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.

2020-08-1737 citations

Accuracy of 68Ga-PSMA-11 for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: A multicenter prospective phase III imaging study.

Journal of Clinical Oncology2020-05-2022 citations

LBA02-05 ACCURACY OF 68GA-PSMA-11 FOR PELVIC NODAL METASTASIS DETECTION PRIOR TO RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION: A MULTICENTER PROSPECTIVE PHASE 3 IMAGING STUDY

The Journal of Urology2020-04-01

Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial.

Journal of Clinical Oncology2020-02-192 citations

Assessment of <sup>68</sup>Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer

JAMA Oncology2019-03-28745 citations

Detection of prostate cancer lesions using Gallium-68 PSMA-11 PET in men with biochemical recurrence following radical prostatectomy.

Journal of Clinical Oncology2018-02-202 citations

Incidence of intrathoracic (IT) metastases detected by <sup>68</sup>Ga-PSMA-11 PET in early stage prostate cancer (PC).

Journal of Clinical Oncology2017-05-201 citations